Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis

Comparative Efficacy of Dapagliflozin and Empagliflozin of a Fixed Dose in Heart Failure: A Network Meta-Analysis

BackgroundThe efficacy of dapagliflozin and empagliflozin in sodium-glucose cotransport-2 inhibitors (SGLT-2i) in patients with heart failure (HF) has been discovered. However, which drug could improve varied prognostic outcomes has not been elucidated. Hence, we compared their efficacies on the pro...

Full description

Bibliographic Details
Main Authors: Zepeng Shi, Feng Gao, Wei Liu, Xuezhi He
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
heart failure
empagliflozin
dapagliflozin
SGLT-2 inhibitor
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2022.869272/full

Similar Items

Similar Items